Cargando…
Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes
Neurodegenerative diseases such as Alzheimer’s disease are characterized by the progressive spreading and accumulation of hyper-phosphorylated tau protein in the brain. Anti-tau antibodies have been shown to reduce tau pathology in in vivo models and antibody-mediated clearance of tau exerted by mic...
Autores principales: | Andersson, Christian Rungsted, Falsig, Jeppe, Stavenhagen, Jeffrey B., Christensen, Søren, Kartberg, Fredrik, Rosenqvist, Nina, Finsen, Bente, Pedersen, Jan Torleif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420568/ https://www.ncbi.nlm.nih.gov/pubmed/30874605 http://dx.doi.org/10.1038/s41598-019-41105-4 |
Ejemplares similares
-
Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau
por: Rosenqvist, Nina, et al.
Publicado: (2018) -
Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
por: Fuller, James P., et al.
Publicado: (2015) -
The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification
por: Kolay, Sourav, et al.
Publicado: (2022) -
Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
por: Kasturirangan, Srinath, et al.
Publicado: (2017) -
Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes
por: Chandupatla, Ram Reddy, et al.
Publicado: (2020)